Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001306619 | SCV001496000 | likely benign | Familial hemophagocytic lymphohistiocytosis 5 | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002543170 | SCV003731219 | uncertain significance | Inborn genetic diseases | 2024-03-19 | criteria provided, single submitter | clinical testing | The c.494G>A (p.R165H) alteration is located in exon 7 (coding exon 7) of the STXBP2 gene. This alteration results from a G to A substitution at nucleotide position 494, causing the arginine (R) at amino acid position 165 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004704518 | SCV005208083 | likely benign | not provided | criteria provided, single submitter | not provided |